Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs

被引:304
作者
Kocbek, P [1 ]
Baumgartner, S [1 ]
Kristl, J [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
关键词
nanoparticles; ibuprofen; melt emulsification method; solvent diffusion method; granules; dissolution rate;
D O I
10.1016/j.ijpharm.2006.01.008
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Poorly water-soluble compounds are difficult to develop as drug products using conventional formulation techniques and are frequently abandoned early in discovery. In the present study, the melt emulsification method traditionally used to prepare solid lipid nanoparticles was adapted to produce drug nanosuspensions. The method was evaluated in comparison with the well known solvent diffusion process for ibuprofen as a model drug. Control of the preparation variables (stabilizers, drug content, homogenization procedure and cooling conditions) allowed formation of nanosuspensions with diameters less than 100 nm. The major advantage of the melt emulsification method over the solvent diffusion method is the avoidance of organic solvents during production, although the mean particle size is slightly greater. The combination of Tween 80 and PVP K25 as stabilizers yields nanosuspensions with the smallest average particle size. The formulation of ibuprofen as a nanosuspension, either in the form of lyophilized powder or granules, was very successful in enhancing dissolution rate, more than 65% of the drug being dissolved in the first 10 min compared to less than 15% of the micronized drug. The increase in in vitro dissolution rate may favourably affect bioavailability and improve safety for the patient by decreasing gastric irritancy. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 25 条
[1]
Intravenous itraconazole emulsions produced by SolEmuls technology [J].
Akkar, A ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (01) :29-36
[2]
Synthesis of nimesulide nanoparticles in the microemulsion Epikuron/isopropyl myristate/water/n-butanol (or isopropanol) [J].
Debuigne, F ;
Cuisenaire, J ;
Jeunieau, L ;
Masereel, B ;
Nagy, JB .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2001, 243 (01) :90-101
[3]
Solubility and solubilization properties of non-steroidal anti-inflammatory drugs [J].
Fini, A ;
Fazio, G ;
Feroci, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :95-102
[4]
Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine [J].
Hecq, J ;
Deleers, M ;
Fanara, D ;
Vranckx, H ;
Amighi, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 299 (1-2) :167-177
[5]
Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone [J].
Jacobs, C ;
Kayser, O ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 214 (1-2) :3-7
[6]
Formulation of amphotericin B as nanosuspension for oral administration [J].
Kayser, O ;
Olbrich, C ;
Yardley, V ;
Kiderlen, AF ;
Croft, SL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) :73-75
[7]
Kipp J., 2003, US Patent, Patent No. [6,607,784, 6607784, 6607784 B2]
[8]
Nanosuspension formulations for low-soluble drugs: Pharmacokinetic evaluation using spironolactone as model compound [J].
Langguth, P ;
Hanafy, A ;
Frenzel, D ;
Grenier, P ;
Nhamias, A ;
Ohlig, T ;
Vergnault, G ;
Spahn-Langguth, H .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2005, 31 (03) :319-329
[9]
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system [J].
Lindenberg, M ;
Kopp, S ;
Dressman, JB .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) :265-278
[10]
DRUG PARTICLE-SIZE REDUCTION FOR DECREASING GASTRIC IRRITANCY AND ENHANCING ABSORPTION OF NAPROXEN IN RATS [J].
LIVERSIDGE, GG ;
CONZENTINO, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (02) :309-313